Examples of DPIs include those with the names Digihaler, Handihaler, Ellipta, Diskus, Pressair, Neohaler, Twisthaler, RespiClick, Redihaler, or Flexhaler. Wixela Inhub is also a DPI. Soft mist ...

Sinus infection, also known as sinusitis, and chronic obstructive pulmonary disease (COPD) often go hand in hand. COPD can raise your risk of sinusitis and make symptoms worse. At the same time, ...

In 2025, World Asthma Day falls on May 6 and carries a strong and urgent message: “Make Inhaled Treatments Accessible for ALL.” This theme, chosen by GINA, reinforces the importance of ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the ...

GSK (NYSE:GSK) reported Q1 2025 results on Wednesday, narrowly beating analysts’ estimates as the British drugmaker’s Specialty Medicines business offset weakness in its Vaccine and General ...

A Medicaid policy change left fewer kids with access to an asthma inhaler Children were more likely to have no asthma inhaler after GlaxoSmithKline withdrew Flovent from the market GSK withdrew ...

(Alliance News) - GSK PLC on Wednesday reported a more than 50% increase in profit in the first quarter of 2025, driven by rising sales in its Specialty Medicines division. The London-based ...

Drugmaker GSK (GlaxoSmithKline) has said it is “well positioned” to cope with any financial impact from changes to US tariff rules. It came as the FTSE 100 giant revealed a rise in sales as ...

GSK is 'well positioned' to deal with the potential implications of any new US tariffs on pharma imports, the group said on Wednesday. President Donald Trump slapped a 10 per cent baseline ...